Biomedical subjects

W H Boyce

Publications and source records attributed to W H Boyce.

At least 73 records · Page 4Linked to original sources

PubMed1976

Ultrasonography as an aid in the diagnosis and management of surgical diseases of the pelvis: special emphasis on the genitourinary system.

Technological advances, particularly the advent of the gray scale technique, has greatly extended the application and usefulness of this modality to clinical diagnoses and surgery. The ultrasonic beam uniquely provides anatomical profiles in the transverse (cross-sectional) and sagittal (longitudinal) planes of the body. Intra-rectal and intra-vaginal ultrasonic probes have provided unique definition of both the normal and pathologic anatomy of the pelvic organs. The present report is drawn from a continuing experience with ultrasonography of the genitourinary system with an update of current technological advances. Ultrasonography has proven especially valuable in the following clinical applications: 1) Early diagnosis of cancer (especially of the prostate); 2) Accurate staging of cancer of the bladder and prostate; 3) Monitoring of the response of the pathologic process to therapy.

Female↗

PubMed1976

Recent progress in ultrasonography of the bladder and prostate.

Gray scale transrectal ultrasonography has proved to be a valuable adjunct in the evaluation of patients with tumors of the prostate and bladder. Its application in patients with prostatic disease is in the detection of early asymptomatic tumors, in the accurate staging of local disease and in the following of patients after the institution of specific treatment. Although it is not being used for the detection of bladder tumors the procedure is a reliable means to evaluate the degree of tumor invasion so that proper therapy can be instituted.

Calculi↗

PubMed1975

Bilirubin as a cholestatic agent. III. Prevention of bilirubin-related cholestasis by sulfobromophthalein.

The administration of sulfobromophthalein sodium (BSP) to manganese-loaded animals had been found to prevent effectively the cholestasis normally created by bilirubin infusion following manganese loading. Measurement of bilirubin levels in blood, liver, and bile in manganese-bilirubin animals with and without BSP fails to provide convincing evidence for a BSP-induced shift in site or magnitude of total bilirubin concentration as an explanation for this anticholestatic action of BSP. Nevertheless, increasing the dose of bilirubin partially reinstitutes the cholestasis. The results are important in that they demonstrate (1) that under certain circumstances intrahepatic cholestasis can be immediately and directly prevented by a pharmacologic agent (by a means not as yet defined) and (2) that the cholestatic activity of bilirubin is, to some extent or under some circumstances, separable from its concentration in blood, liver, and bile.

Animals↗

PubMed1975

Bilirubin as a cholestatic agent. IV. Effect of bilirubin and sulfobromophthalein (BSP) on biliary manganese excretion.

These experiments demonstrate that the adminstration of bilirubin does not significantly alter biliary manganese excretion in manganese-loaded animals. Sulfobromophthalein sodium (BSP), which has been shown to afford prophylaxis against manganese-bilirubin cholestasis, significantly increases the biliary excretion of manganese. These results are meaningful in that they indicate that the amount of manganese per se in the bile is not critical in this cholestasis, and suggest that intracanalicular reactions are probably not etiologically critical in this model. They point to the conclusion that the critical cholestatic events are occurring within the hepatocyte. The results also indicate that the biliary excretion of manganese is obligate, and to some extent independent of bile flow. The critical cholestatic events are presumably mediated through the biochemical effects of either a manganese-bilirubin complex or of manganese and bilirubin acting separately but synergistically.

Animals↗

PubMed1975